Literature DB >> 8881576

[Treatment with octreotide of stenosing cystic dystrophy on heterotopic pancreas of the duodenal wall].

V de Parades1, D Roulot, L Palazzo, S Chaussade, P Mingaud, J Rautureau, T Coste.   

Abstract

Cystic dystrophy of the duodenal wall developing in heterotopic pancreas is a rare disease. Weight loss and painless vomiting due to duodenal stenosis where the main clinical manifestations of this entity in a chronic alcoholic patient. Diagnosis was made by using an ultrasonic-endoscope equipped with a miniprobe. Although surgical treatment is usually recommended in this situation, the clinical condition of this patient improved dramatically after subcutaneous injections of somatostatin analog (octreotide). This treatment was maintained during 9 months and no recurrence was observed during the follow-up period.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8881576

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  4 in total

1.  Dual-phase CT findings of groove pancreatitis.

Authors:  Atif Zaheer; Maera Haider; Satomi Kawamoto; Ralph H Hruban; Elliot K Fishman
Journal:  Eur J Radiol       Date:  2014-05-27       Impact factor: 3.528

2.  "Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution.

Authors:  L Casetti; C Bassi; R Salvia; G Butturini; R Graziani; M Falconi; L Frulloni; S Crippa; G Zamboni; P Pederzoli
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

3.  Pancreas-preserving duodenal resections vs pancreatoduodenectomy for groove pancreatitis. Should we revisit treatment algorithm for groove pancreatitis?

Authors:  Vyacheslav Egorov; Roman Petrov; Aleksandr Schegolev; Elena Dubova; Andrey Vankovich; Eugeny Kondratyev; Andrey Dobriakov; Dmitry Kalinin; Natalia Schvetz; Elena Poputchikova
Journal:  World J Gastrointest Surg       Date:  2021-01-27

4.  Pancreas-preserving approach to "paraduodenal pancreatitis" treatment: why, when, and how? Experience of treatment of 62 patients with duodenal dystrophy.

Authors:  V I Egorov; A N Vankovich; R V Petrov; N S Starostina; A Ts Butkevich; A V Sazhin; E A Stepanova
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.